Pharmacy/Drug Medical Policy Update July 20, 2021
Medical Guidelines | Reason for Update |
Dostarlimab-gxly (Jemperli) | Original medical policy criteria issued. |
Loncastuximab tesirine-lpyl (Zynlonta™) | Original medical policy criteria issued. |
Medical Guidelines | Reason for Update |
Dostarlimab-gxly (Jemperli) | Original medical policy criteria issued. |
Loncastuximab tesirine-lpyl (Zynlonta™) | Original medical policy criteria issued. |